Canadian Registry of ICD Implant Testing Procedures

Guidant Corporation261 enrolled

Overview

To document practices in Canadian ICD implant centres around defibrillation therapy efficacy testing.

To document types of defibrillation testing (DFT) procedures are in current use in Canada, rates of use an dno use of DFT testing, medical indications for non use of DFT testing, rate of successful testing of first lead configuration, rates and types of complications from DFT testing, costs of implant procedures and the costs associated with DFT testing, short term outcomes of patients with different types of implant procedures.

Study Type

OBSERVATIONAL

Enrollment

261

Conditions

Ventricular Fibrillation

Interventions

GUIDANT ICD SYSTEMDEVICE

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Receiving a Guidant ICD system, including replacements Exclusion Criteria: * New epicardial lead(s) implanted, included in another cardiovascular trial (may be in the ELECTION Study)

Outcomes

Primary Outcomes

to systematically collect and quanitfy characteristics of ICD implant procedures in Canadian Hospitals

Time frame: 3 years

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.